Respiratory Support Patterns, Pneumothorax Incidence, and Factors Associated with Invasive Intubation among Critically Ill COVID-19 Patients Admitted to the ICU
Abstract
Background: Critically ill patients with coronavirus disease 2019 (COVID-19) often require escalation of respiratory support, such as non-invasive ventilation and invasive mechanical ventilation. While invasive ventilation can be lifesaving, it is associated with risks of ventilator-induced lung injury and barotrauma, including pneumothorax. The present study evaluated respiratory support patterns, clinically documented pneumothorax, and factors associated with invasive intubation among critically ill COVID-19 patients admitted to the intensive care unit of Al-Zahra Hospital in Isfahan, Iran.
Methods: This retrospective observational cohort study included 152 adult patients with confirmed COVID-19 admitted to the intensive care unit. Demographic characteristics, recorded hospital stay/duration, early laboratory values, arterial blood gas indices, respiratory support modalities, airway interventions, and clinically documented pneumothorax were extracted from medical records. Patients were compared according to invasive intubation status. Continuous variables were compared using the Mann–Whitney U test, and categorical variables were compared using the chi-square test with continuity correction or Fisher’s exact test, as appropriate. Exploratory multivariable logistic regression was performed to identify variables independently associated with invasive intubation.
Results: The mean age was 58.49 ± 13.94 years, and 87 patients (57.2%) were male. Non-invasive ventilation was required in 34 patients (22.4%), while 82 patients (53.9%) underwent endotracheal intubation and invasive mechanical ventilation. Re-intubation occurred in 7 patients (4.6% of the total cohort; 8.5% of intubated patients), and tracheotomy was performed in 6 patients (3.9% of the total cohort; 7.3% of intubated patients). Clinically documented pneumothorax occurred in 2 patients, corresponding to 1.3% of the total cohort and 2.4% of intubated patients. Compared with non-intubated patients, intubated patients were older and had higher blood urea nitrogen, creatinine, PaCO2, activated partial thromboplastin time, D-dimer, C-reactive protein, and ferritin levels, as well as lower hemoglobin concentration, lower platelet count, and lower arterial pH. In exploratory multivariable analysis, higher blood urea nitrogen, lower hemoglobin concentration, lower platelet count, and higher C-reactive protein were independently associated with invasive intubation.
Conclusion: In this single-center cohort of critically ill COVID-19 patients, the requirement for invasive respiratory support was substantial, while clinically documented pneumothorax was infrequent. Patients who required invasive intubation exhibited greater renal, inflammatory, hematologic, coagulation, and acid-base abnormalities compared to non-intubated patients. These findings are hypothesis-generating and non-causal due to the retrospective design, limited ventilatory mechanics data, and the small number of pneumothorax events.
[2] Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2021; 325(20):2120.
[3] Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20):2098.
[4] COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021; 47(1):60-73.
[5] Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020; 368(6490):473-4.
[6] Grieco DL, Bongiovanni F, Chen L, Menga LS, Cutuli SL, Pintaudi G, et al. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies. Crit Care. 2020; 24(1):529.
[7] Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020; 46(5):854-87.
[8] McGuinness G, Zhan C, Rosenberg N, Azour L, Wickstrom M, Mason DM, et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020; 297(2):E252-62.
[9] Belletti A, Landoni G, Zangrillo A. Pneumothorax and barotrauma in invasively ventilated patients with COVID-19. Respir Med. 2021; 187:106552.
[10] Gazivoda VP, Ibrahim M, Kangas-Dick A, Sun A, Silver M, Wiesel O. Outcomes of barotrauma in critically ill COVID-19 patients with severe pneumonia. J Intensive Care Med. 2021; 36(10):1176-83.
[11] Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-8.
[12] Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015; 372(8):747-55.
[13] Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363(12):1107-16.
[14] RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384(8):693-704.
[15] Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020; 383(19):1813-26.
[16] Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020; 98(1):209-18.
[17] Ferro A, Kotecha S, Auzinger G, Yeung E, Fan K. Systematic review and meta-analysis of tracheostomy outcomes in COVID-19 patients. Br J Oral Maxillofac Surg. 2021; 59(9):1013-23.
| Files | ||
| Issue | Article in Press |
|
| Section | Research Article(s) | |
| Keywords | ||
| COVID-19 Intensive care unit Mechanical ventilation Non-invasive ventilation Pneumothorax Barotrauma Mortality | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |


